We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Consolidation Provides Free Access to DNA Sequence Information

By LabMedica International staff writers
Posted on 11 Jun 2010
Print article
Three major sequence resources have consolidated to become Europe's primary access point to globally concise DNA and RNA sequence data.

The European Nucleotide Archive (ENA) is freely available from the European Bioinformatics Institute (EMBL-EBI; Cambridge, UK), a part of European Molecular Biology Laboratory.

Faster and low cost DNA sequencing has led to previously unheard of amounts of data being deposited in the public nucleotide sequence databases: today, ENA holds over 20 terabases of nucleotide sequence which, combined with associated information (annotation), occupies 230 terabytes of disk space. Thoroughly annotated and crosslinked sequence records from the EMBL Nucleotide Sequence Database (EMBL-Bank) form the backbone of the ENA. But significantly, ENA now also provides direct access to raw sequence data: the European Trace Archive contains raw data from electrophoresis-based sequencing machines and was previously maintained at the Wellcome Trust Sanger Institute (Cambridge, UK); the Sequence Read Archive (SRA) is a newly established repository for raw data from next-generation (array-based) sequencing platforms. Improved submission and data-access tools make it easier for ENA's users to share their sequence data.

"Large-scale DNA sequencing was previously the domain of a small number of specialist labs, but next-generation sequencing has made it accessible to the majority of molecular life scientists,” explained Graham Cameron, the EMBL-EBI's associate director. "The launch of ENA reflects our continuing commitment to promoting scientific progress by providing global access to nucleotide sequence information. This has been central to EMBL's mission since the 1980s when we launched the EMBL Data Library.”

Guy Cochrane, who leads the ENA team, stated that "ENA has been designed to provide our users with improved access both to annotated and to raw sequence data through the same user-friendly interface. It provides graphical browsing, web services, text search, and a new rapid sequence similarity search. ENA also provides access to related information, with over 190 million cross references to external records, many of which are in other EMBL-EBI data resources.”

The ENA team plans to launch many new features for the resource over the next twelve months, including enhancements to the user-friendly browser, improved interactive submissions tools, and organism- and project-centered portals into ENA data.

Tim Hubbard, head of informatics at the Wellcome Trust Sanger Institute, said, "As major generators of DNA sequence data, it is important to us that the research community has ready access not only to annotated sequence information, but also to raw data. It's great to see the launch of ENA with new interfaces for users to this vast and rapidly growing body of information.”

Related Links:

European Bioinformatics Institute

New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO
New
Progesterone Serum Assay
Progesterone ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.